Evidence map›Paper›PMID 34830917›Full record

ArticleCancers2021

X-ray-Fluorescence Imaging for In Vivo Detection of Gold-Nanoparticle-Labeled Immune Cells: A GEANT4 Based Feasibility Study.

Arthur Ungerer, Theresa Staufer, Oliver Schmutzler, Christian Körnig, Kai Rothkamm, Florian Grüner

Abstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Assessing Cellular Uptake of Exogenous Coenzyme QAntioxidants (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Arthur UngererUniversity Medical Center Hamburg-Eppendorf, Department of Radiotherapy and Radiation Oncology, Medical Faculty, University of Hamburg, Martinistraße 52, 20246 Hamburg, Germany.
Theresa StauferUniversität Hamburg and Center for Free-Electron Laser Science (CFEL), Institute for Experimental Physics, Faculty of Mathematics, Informatics and Natural Sciences, University of Hamburg, Luruper Chaussee 149, 22761 Hamburg, Germany.
Oliver SchmutzlerUniversität Hamburg and Center for Free-Electron Laser Science (CFEL), Institute for Experimental Physics, Faculty of Mathematics, Informatics and Natural Sciences, University of Hamburg, Luruper Chaussee 149, 22761 Hamburg, Germany.
Christian KörnigUniversität Hamburg and Center for Free-Electron Laser Science (CFEL), Institute for Experimental Physics, Faculty of Mathematics, Informatics and Natural Sciences, University of Hamburg, Luruper Chaussee 149, 22761 Hamburg, Germany.
Kai RothkammUniversity Medical Center Hamburg-Eppendorf, Department of Radiotherapy and Radiation Oncology, Medical Faculty, University of Hamburg, Martinistraße 52, 20246 Hamburg, Germany.ORCID 0000-0001-7414-5729
Florian GrünerUniversität Hamburg and Center for Free-Electron Laser Science (CFEL), Institute for Experimental Physics, Faculty of Mathematics, Informatics and Natural Sciences, University of Hamburg, Luruper Chaussee 149, 22761 Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing field of cellular therapies in regenerative medicine and oncology calls for more refined diagnostic tools that are able to investigate and monitor the function and success of said therapies. X-ray Fluorescence Imaging (XFI) can be applied for molecular imaging with nanoparticles, such as gold nanoparticles (GNPs), which can be used in immune cell tracking. We present a Monte Carlo simulation study on the sensitivity of detection and associated radiation dose estimations in an idealized setup of XFI in human-sized objects. Our findings demonstrate the practicability of XFI in human-sized objects, as immune cell tracking with a minimum detection limit of 4.4 × 10

Indexed as

GEANT4gold nanoparticlesimmune cellimmunotherapytrackingXFIX-ray fluorescence

Identifiers

PMID34830917
PMCPMC8616134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.